197
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Caspofungin: an overview

Pages 697-705 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

N. Mehyar, A. Mashhour, I. Islam, S. Gul, A.O. Adedeji, A.S. Askar & M. Boudjelal. (2021) Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase. SAR and QSAR in Environmental Research 32:1, pages 51-70.
Read now

Articles from other publishers (5)

Sushant Sunder, Kriti Bhandari, Shruti Sounkaria, Manjari Vyas, Bhupendra Pratap Singh & Prakash Chandra. (2023) Antibiotics and nano-antibiotics in treatment of lung infection: In management of COVID-19. Microbial Pathogenesis 184, pages 106356.
Crossref
Nicolas Schlosser, Jordi Espino-Martínez, Florian Kloss, Florian Meyer, Bettina Bardl, Miriam A. Rosenbaum & Lars Regestein. (2021) Host nutrition-based approach for biotechnological production of the antifungal cyclic lipopeptide jagaricin. Journal of Biotechnology 336, pages 1-9.
Crossref
Anchala Kumari, Nidhi Shrivastava, Mohit Mishra, Pallavi Somvanshi & Abhinav Grover. (2021) Inhibitory mechanism of an antifungal drug, caspofungin against amyloid β peptide aggregation: Repurposing via neuroinformatics and an experimental approach. Molecular and Cellular Neuroscience 112, pages 103612.
Crossref
Joseph Taboada & Amy M Grooters. 2008. Small Animal Clinical Pharmacology. Small Animal Clinical Pharmacology 186 197 .
M. Siepmann. 2006. Praktische Arzneitherapie. Praktische Arzneitherapie 1105 1120 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.